HLS Therapeutics Inc (TSE:HLS) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
HLS Therapeutics Inc. is set to release its Q3 fiscal 2024 financial results on November 7, 2024, with a conference call to follow discussing the results. The company, which specializes in pharmaceutical products for psychiatric disorders and cardiovascular disease, continues to focus on North American markets.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.